We are live on ! Find out more
PFE icon

Pfizer
PFE

Fund managers haven’t disclosed any holdings of PFE yet.

PFE Hedge Fund Activity: Q1 2026 in Review

2,937 of the 8,129 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2026, worth a combined $106B — up 14% from $93B a quarter earlier.

Buyers outnumbered sellers: 254 funds opened new PFE positions and 168 closed out — a net gain of 86 holders — while 1,297 added to existing stakes and 1,082 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $1.41B. The largest seller was BNP Paribas Financial Markets, cutting an estimated $176M.

  • 2,937 institutional investors held Pfizer (PFE) as of Q1 2026, up from 2,905 in Q4 2025.
  • Funds reported $106B of Pfizer stock for Q1 2026, up 14% quarter-over-quarter.
  • 254 funds opened new Pfizer positions in Q1 2026 and 168 closed out, a net change of +86 holders.
  • The largest Pfizer buyer in Q1 2026 was Fisher Asset Management, an estimated $1.41B added.
  • The largest Pfizer seller in Q1 2026 was BNP Paribas Financial Markets, an estimated $176M sold.

Based on aggregated 13F filings for Q1 2026.